Podcast appearances and mentions of James Bond

In their last go of 2025, the guys tell the tale of a surprisingly lucky boy forced into the British Navy and an audacious commando strike gone wrong, and predict the next James Bond. Thanks to our sponsor The Wolf Project for making this happen! The Wolf Project – Wolfproject.co Sources: Lessons From History: Hidden heroes and villains of the past, and what we can learn from them  More Lessons From History

In our final episode of the year we've got some big surprises. Counselor Zachariah finds out his mom has a secret half-brother! Speaking of brotherly love, we also get into our love for the Jonas Brothers Christmas movie, judge some truly unwell neighbor holiday decor, and make an important announcement: we're taking a short break from the podcast, but we'll be back in the new year. Plus, we get into a James Bond jewel thief, and Quinta Brunson's field trip fund. Obviously we have to wrap up the year with some ranting and question why skydivers are scattering ashes… in the sky? Also what the even heck is up with the GPS screaming directions at full volume while we are posing at a public rest stop?? And of course, we end on the important stuff: ribbon candy love, baking timelapse obsession, and a couple songs to carry you into the season. Your civic duty as campers begins now: vote in the Nunu Nana Awards at CampCounselorsPodcast.com/vote! Winners announced in the 2nd annual Nunu Nana Award Ceremony on January 14, 2026.This episode was mixed and edited by Kevin Betts.Get your tickets to see Zachariah Porter's new Live Comedy Tour!Want BONUS CONTENT? Join our PATREON!Sponsors:➜ For a limited time, get $35 off Aura's best-selling Carver Mat frame (Wirecutter's #1 pick) at AuraFrames.com with promo code: CAMP➜ Bring your A-game and talk to your doctor. Learn more at Apretude.com or call 1-888-240-0340.➜ Go to BollAndBranch.com/camp to get up to 25% off sitewide! Exclusions apply. See site for details.Works Cited:➜ Corlett, Eva. “Man Charged with Theft after Allegedly Swallowing Fabergé Pendant in Jewellery Store.” The Guardian, 2 Dec. 2025. ➜ Gonzalez, Alex. “Quinta Brunson Launches ‘Field Trip Fund' For Philadelphia Schools.” Complex, 5 Dec. 2025.Camp Songs:Spotify Playlist | YouTube Playlist | Sammich's Secret MixtapeSocial Media:Camp Counselors TikTokCamp Counselors InstagramCamp Counselors FacebookCamp Counselors TwitterSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Julie and Steve Bernstein are animation stars as composers, orchestrators, arrangers, songwriters and singers. Each has won multiple Emmy Awards. They've worked on hit TV series like Animaniacs, Pinky and the Brain, and Freakazoid. Their Animated feature films include A Flintstones Christmas Carol, and Tom and Jerry: Blast Off to Mars. In other respects, Julie has written string quartet arrangements for Tierney Sutton, Sophie Carpenter and others. And Steve has written scores for horror films and documentaries, and he was the conductor for the James Bond film Skyfall and for The Perfect Storm starring George Clooney.My featured song is “The Pardners”, from the album East Side Sessions by my band Project Grand Slam. Spotify link.—-----------------------------------------------------------The Follow Your Dream Podcast:Top 1% of all podcasts with Listeners in 200 countries!Click here for All Episodes Click here for Guest List Click here for Guest Groupings Click here for Guest TestimonialsClick here to Subscribe Click here to receive our Email UpdatesClick here to Rate and Review the podcast—----------------------------------------CONNECT WITH THE BERNSTEINS:www.stevebernstein.biz—----------------------------------------ROBERT'S LATEST SINGLE:“MA PETITE FLEUR STRING QUARTET” is Robert's latest release. It transforms his jazz ballad into a lush classical string quartet piece. Praised by a host of classical music stars.CLICK HERE FOR YOUTUBE LINKCLICK HERE FOR ALL LINKS—---------------------------------------ROBERT'S RECENT SINGLE“MI CACHIMBER” is Robert's recent single. It's Robert's tribute to his father who played the trumpet and loved Latin music.. Featuring world class guest artists Benny Benack III and Dave Smith on flugelhornCLICK HERE FOR YOUTUBE LINKCLICK HERE FOR ALL LINKS—--------------------------------------ROBERT'S LATEST ALBUM:“WHAT'S UP!” is Robert's latest compilation album. Featuring 10 of his recent singles including all the ones listed below. Instrumentals and vocals. Jazz, Rock, Pop and Fusion. “My best work so far. (Robert)”CLICK HERE FOR THE OFFICIAL VIDEOCLICK HERE FOR ALL LINKS—----------------------------------------Audio production:Jimmy RavenscroftKymera Films Connect with the Follow Your Dream Podcast:Website - www.followyourdreampodcast.comEmail Robert - robert@followyourdreampodcast.com Follow Robert's band, Project Grand Slam, and his music:Website - www.projectgrandslam.comYouTubeSpotify MusicApple MusicEmail - pgs@projectgrandslam.com  

On Episode 143 of The Film ‘89 Podcast it's that time of year again. Towards the end of every year since 2022, Film ‘89 has celebrated the 60th anniversary of a James Bond film. In 2022 we started with Dr. No, in 2023 we covered From Russia With Love and last year we covered Goldfinger. Now Skye and one of the greatest film poster artists working in the business today, Tony Stella, return to celebrate the 60th anniversary of the fourth James Bond film, Thunderball, which had its world premiere in Tokyo, Japan on December 9th 1965. Thunderball came out at the very peak of Bondmania. Sean Connery was approaching mega star status and the books and films were as popular as they would ever be. Made on a budget that was more than the combined budgets of the previous three films, Thunderball was a hugely ambitious film with complex underwater action sequences the likes of which audiences had never seen before and it would go on to become the most successful Bond film ever, and based on ticket sales alone, it still is. So get on your wetsuit, pick up your spear-gun and join Skye and Tony as they take the deep dive on what they feel is one of the most underrated of all James Bond films.

Check out Cam's latest novel / audio drama here! Somehow, this French indie movie is both the best James Bond movie and best Batman / Catwoman movie ever made. In this episode, we're investigating the endless, delirious style of Reflection of a Dead Diamond. Topics include: the art of rug pull revelations, how to balance realism and surrealism, and the enduring cultural influence of Frank Miller's Dark Knight Returns. LINKS: Patreon, YouTube, Spotify, Instagram Feedback & Theories: secondbreakfastpod@gmail.com

James Bond doesn't just have a License to Kill—he's got a License to Survive. In this episode of Cracking the Code of Spy Movies, hosts Dan and Tom take you on a thrilling journey through the 25 Eon Productions James Bond films to uncover the countless times 007 has stared death in the face and walked away unscathed. From the iconic laser scene in Goldfinger to the crocodile run in Live and Let Die, the ski jump in The Spy Who Loved Me, and even a space station shootout in Moonraker, Bond's death-defying escapes are legendary. We'll explore the concept of plot armor, the gadgets from Q Branch that save Bond's life, and the sheer audacity of stunts that changed cinema forever. How does Bond survive avalanches, sharks, and explosions without a scratch? Is it skill, luck, or just great writing? And why did his streak finally end in No Time to Die? Packed with humor, insider trivia, and a chronological countdown of Bond's greatest escapes, this episode is perfect for spy movie fans, action lovers, and anyone fascinated by the art of cinematic survival. Whether you're a lifelong Bond enthusiast or new to the franchise, you'll discover why James Bond remains the ultimate escapist hero. Join us as we decode the thrills, the near misses, and the moments that made audiences gasp. Subscribe now so you never miss an episode of Cracking the Code of Spy Movies. Tell us what you think about how James Bond's Licence to Survive What's your favorite James Bond's cheating death scene?  Drop us a note and let us know. Let us know your thoughts, ideas for future episodes, and what you think of this episode. Just drop us a note at info@spymovienavigator.com.  The more we hear from you, the better the show will surely be!  We'll give you a shout-out in a future episode!   You can check out all our CRACKING THE CODE OF SPY MOVIES podcast episodes on your favorite podcast app or our website. In addition, you can check out our YouTube channel as well.   Episode Webpage:  https://bit.ly/4al2dRs

Retatrutide is years away from FDA approval and yet the fight over access, price, control of this medication is already well underway. That's what this podcast is going to be about today. There's well over a hundred thousand people by my estimates who are already on some form of this medication today. And that should tell you enough about how disruptive this molecule is and will be. It is a game changer among game changer. We've been talking about it for three years here at On The Pen, well before any of your favorite gym bros were talking about Retatrutide. We were talking about Reta, who tried Retatrutide here at On The Pen. And that's because we identified this triple agonist as a game changer among game changers. So This is going to be a very Retatrutide heavy episode, and so I hope you'll join us and stick with us if this is a topic you enjoy, because I think this is really going to effectively lay the groundwork for what accessibility to this medication will look like. So let's get into it. Welcome to the On The Pen Podcast with your host, Dave Knapp. Welcome to the On The Pen, the weekly dose podcast. This is our weekly roundup in incretin memetic news. And frankly, there's no news that is bigger than Reta-Trutide news. Just find me any news that is bigger than the data that we got on Reta-Trutide. Now, we already did a video about the Triumph Phase II clinical trials that we got in osteoarthritis of the knee. You can go back and check out that video if you'd like more data. So we're not gonna super... rehash the data. We'll go over at a high level what the data showed us. We're not going to go over how the medicine works, because by now we all know that it's the triple agonist, right? If terzapatide was a dual agonist, GLP-GIP, Retatrutide is the triple agonist that adds to it a glucagon component, which is absolutely just shredding, shredding liver fat. It is absolutely revving up people's metabolism and showing a tremendous amount of weight loss. So let's get into what the weight loss looked like in this first trial, because there are longer obesity trials where, where the primary outcome is the weight loss this was again a specific trial in measuring pain reduction in folks with osteoarthritis of the knee but check out these numbers these are placebo adjusted meaning it's taking the two percent out that people lost on placebo but looking at these numbers Folks on one milligram over forty eight weeks lost seventeen percent. They bumped up to four milligrams. Those folks lost twenty two percent. So right there at the lowest dose, you're already reaching the efficacy of today's drugs that are on the market, like triseptide and semaglutide in their various forms. If you bumped up to eight milligrams, you saw twenty four percent placebo adjusted weight loss and at twelve milligrams, twenty six point four percent weight loss. Adding back in that two percent of the placebo that those on placebo loss, that's twenty eight point four percent weight loss in these forty eight weeks at the highest dose. When you adjust for some of the more real world outcomes, you kind of ding the numbers a little bit based upon people who quit the drug, et cetera. Those numbers look more like a twenty percent weight loss and twenty three point seven percent weight loss at the highest dose. But even then, you're still seeing a drug that is better than the current drugs that are on the market. around forty eight percent of patients on Retatrutide lost greater than twenty five percent. And then if you were at that twelve twelve milligram dose, that highest dose patients lost fifty nine percent of patients lost more than twenty five percent of their body weight. There was a subset that lost thirty percent of their body weight and some even over thirty five percent of their body weight on Retatrutide. So the lower doses compete with today's best drugs and the upper doses are entering into bariatric surgery level weight loss. And that's putting the whole obesity system on notice and probably a lot of surgeons nervous because typical body weight loss was something like the street sleeve gastrectomy. For example, it's about eighteen to twenty five percent body weight. The Roux-en-Y gastric bypass twenty five to thirty five percent weight loss or the duodenal switch thirty to forty percent weight loss. So the upper doses of Ritutrutide overlap with sleeve and bypass outcomes without any surgery. It's incredible. It is a game changer among game changer. It is the new benchmark in obesity medicine. And there's actually more data, like I said, landing in later twenty twenty six. The longer duration will historically, if history is a marker, equal more weight loss than we even see here at this forty eight weeks. We have an interview that will be airing later this week on our channel and on our podcast with our friend Mimi from Australia who just wrapped up her clinical trial on Retatrutide. They ended it like ten weeks early on her, which was a huge bummer to her. So we're going to hear from her because she had to end abruptly. We're going to hear her story, an incredible story. She's one of those folks that got up that thirty five percent body weight loss in the time that she was on Retatrutide. So, this is just showing you that these drugs are not simply an alternative to bariatric surgery. We are approaching a point in time where these are on par with bariatric surgery, and as people are on this Reta-Trutide trial, you see that these numbers aren't plateauing either. So we will see stronger weight loss numbers the longer that these folks are on this trial. And I think you'll see some of those numbers in that population of folks on the higher doses eclipse maybe even some of what we see with some of these bariatric surgeries. the real story that i think is taking shape here is not in how powerful Retatrutide is because we've literally been expecting or anticipating this kind of data for more than three years at on the pin we've been talking about this and i think that's sort of reflected in the fact that you didn't see this massive spike in eli lilly stock wall street was expecting this as well Um, so it was on par, I think with expectations, but the expectations are astronomical compared to previous options that were available to patients and all the innovation in the world. All of these drugs, we talked at last week about WV, E double Oh seven, the James Bond of weight loss that targets fat, not only targets fat loss, but it also targets the promotion of building of, of lean muscle mass. We're talking about an insane future in obesity medicine. But none of it means anything if people can't access it. And that's really where we are today in terms of ensuring that there's going to be an option for everyone. And that's sort of what I want to get into today, because Lilly wants Retatrutide to be classified as a biologic, so not a traditional small molecule drug like you've seen every other incretin and nutrient-stimulated hormone-treating obesity on the market to date. They're trying to get this classified as a biologic. Now, we talked about this before on the podcast. That matters in three major ways. It affects the exclusivity length of time that a pharmaceutical company has on a drug. That goes from, I believe, five years of market exclusivity to twelve. It affects compounding rules because biologics cannot be compounded. And then that gives the pharmaceutical companies a tremendous amount of pricing power in the marketplace, because essentially there's no competition and there's no competition for a long time. But this whole argument about getting this classified as a biologic is not about safety. It's about protection and we're going to get into it. So let's explain this here. This is why Retatrutide really is not a biologic arguably. So biologics are large proteins. There are hundreds of or even thousands of amino acids grown in living cells that are sensitive to tiny manufacturing changes. Retatrutide is a short chain peptide. It's chemically synthesized and it is below the traditional biological size thresholds when it comes to how those things are defined. We'll just leave it at that. So even though it acts like a biologic in the body, it's made like a drug. It's made like a small molecule drug. And if it's treated as a drug, they get, like I said, five years of market exclusivity. Now, really a lot of confusion around what this means, but essentially the first five years of the life of a drug, the patent can be challenged for a number of reasons. We've seen patent challenges right now are going on in the courts for both semaglutide and terzepatide. But these companies are guaranteed that five years of market exclusivity, no matter how those patent lawsuits shake out. That five years jumps to twelve years with the biologic. So ultimately, there's no biosimilars that are allowed during that twelve year window. Again, with terzapatidin and semaglutide, it's five years. They could lose their market exclusivity within five years of the release of the patent. twelve years with a biologic. So if they lose their patent challenges on Trezabitide, they still have some time left with market exclusivity for the drug. They likely will not lose those, but that jumps to twelve years. And I think the most important thing to understand about the reclassification of Reta-Trutide to a biologic would mean that, 503A and 503B pharmacies are effectively locked out of compounding this medication, 503Bs would have some latitude arguably, but they would face extreme barriers. Routine compounding becomes legally and technically restricted because biological status doesn't slow compounding down. It actually shuts the door or almost completely shuts the door. Biologics not only would allow Lilly to have longer market exclusivity, no compounding, but it would allow them to command a higher price in the marketplace because A, they get this designation and there's an assumption when they bring this to market that they're harder to manufacture, that they're harder to copy, that there are fewer negotiating alternatives for payers. They can command a higher price with the insurance companies, and the price pressure stays muted for much longer because, again, you don't have those pressures of compounding. You don't have the pressures externally from lawsuits that could end your market exclusivity in that first five years of the drug's existence. So there's just a lot of price pressure upwards on a biologic compared to a normal small molecule drug. And when there's no credible alternative or backup option, which to Retatrutide, there wouldn't be, it'd be the first drug that has bariatric surgery level results. The prices won't come down. They'll command a massive price and the prices won't come down. So let's talk about where this currently stands because ultimately the Eli Lilly went to the FDA. We've been covering this for well over a year, maybe close to two years now, a year and a half at least. Lily went to the FDA, they said, we want this classified as a biologic, here are the reasons why. The FDA initially said, no, we're not gonna do that. So Lily challenged that decision in court. So the point that we're at today is the court told the FDA to reconsider and better explain itself So the first no given to the FDA to Lilly didn't stick. The courts looked at it and they said, you need a better, you need to reconsider your decision and you need to explain your decision better to Lilly. So ultimately we're sitting now at the point where the court has made its decision that the FDA has to go back and now we await basically what the FDA has to say on this. But if this thing is classified as a biologic, that would be a massive massive loss for patients. Now, again, we're, we're focusing on the accessibility of this drug into the future. And, and I think that this is an important conversation to have. One of the interesting points that I have to bring into the conversation is the fact that I got to sit in on a, on a closed session question and answer with the media. I didn't get to answer or, excuse me, excuse me, ask a question at this time, but shortly after the most favored nations announcement, with eli lilly and the trump administration in the oval office that day there was a press briefing that i was invited to dave ricks was asked by max bayer reporter of endpoints who we've interviewed here on this very podcast and he was asked was Retatrutide included in the most favored nations discussions meaning will we get a cash pay version of Retatrutide uh that is you know circumventing the pbms uh will we get these cheaper prices will will it be be two hundred fifty dollars also and there was a hard no there was a hard no like no that was not included that was not part of these discussions even though what we heard from the trump administration was that those these companies that were jumping on to the most favored nations agreement were also agreeing to offer future drugs at most favored nations pricing now was lily saying that no they're not going to offer it at the it wasn't part of the negotiations in terms of the price points that they had discussed for triseptide maybe or did it mean altogether there won't be a cash pay option of this medication i don't know um that we would love to get clarity on But I highly doubt we're going to get any more information than necessary at this point in time. So, Reta-Trutide is being positioned to be a drug that, and well so, should be offered at a premium. This is a drug that is far exceeding the current drugs that are on the market. I think that we're gonna see even the indications of Reta-Trutide far beyond simple obesity, but it is going to be their crown jewel for the next decade, more than likely. Reta-Trutide is going to be a massive drug, and so they're attempting to build a moat around it. And these are things that we need to be aware of as a community so that we can hold our positions and conversations about these and basically, you know, be able to articulate to people in positions of power like this is an important thing to us. This is an important thing in the advocacy of obesity and sort of the next frontier of the fight of accessibility, which marches on. each and every day because of course the current drugs, while as great as they are and as much as access is expanding, there are still people with sicker or rather more advanced versions of metabolic disease that are gonna need these newer treatments and price is going to be a huge factor. So let's talk about the gray market right now because I think it's also nearly impossible to talk about this topic without including a discussion about the gray market because there are, as I mentioned at the outset, hundreds of thousands of people on this medication already. So research grade Retatrutide exists. It's in the gray markets of the Internet. It's where people are going and they're buying, you know, basically versions of these these peptides that are made in factories overseas. They're being imported into the United States, oftentimes illicitly in shipments that are marked as something else. The FDA has tried to crack down. There's no doctor involved in this. It's a very, that's why it's called the gray market, right? So it's not a prescription medicine, but the demand for this is massive. And all you have to do is really scroll your TikTok for about fifteen minutes. You're going to come across a insane amount of content on the topic of Retatrutide. An insane amount of, and oftentimes, you know, what I find most disturbing is oftentimes it looks like very young people. very young people taking Retatrutide. Crazy, it's crazy. But the demand is massive and there's a whole gray market for it proliferating over on TikTok and in the far reaches of the internet. And I would estimate that tens, if not hundreds of thousands of people are already or have already used it. And I think it's a testament to a to to the effectiveness of this drug. It's also a testament to the fact that there needs to be more guardrails, I think, around this stuff than there currently is, because gray markets appear and they thrive when legal access lags the reality of the demand for the medication. And you saw this earlier this week as we launched a petition to fight back against the Safe Drug Act of twenty twenty five, a drug, a drug act that is in theory designed to put guardrails around compounding. But in practice, I think is creating a new battlefield for Eli Lilly and Novo Nordisk to shut down compounding on the current classes of medications, which is why We as a community need to be loud about our opposition to it. If they were really concerned about the safety of compounds, they would do two very simple things. They would require reporting around the active pharmaceutical ingredient of a compound. Patients ought to be able to know where the actual source of their medication is coming from. And they should know that those places are FDA approved and inspected. And the second thing is they should require adverse event reporting. Those are required of 503Bs. They should be required of 503As as well. 503As are making a tremendous amount of money. They're making thousands and thousands of these scripts. So when there are adverse events, they should be required to report those to the FDA. Simple. None of that is in this bill. None of it. None of it. Instead, it seeks to put caps on the amount of compounds that can be made by a compound pharmacy without them having to report to the FDA. And then it seeks to codify the definition of essential copy. Again, all of these things that will become law and then argued in court and then a battlefield for Lilly to potentially win a legal battle and thwart compounding. It's creating a new battlefield for them. They're losing in the courts. They're losing with the current language that exists in the Food, Drug, and Cosmetic Act. So we create new language. We create new law. Just vague enough to pull some threads and hopefully win something in court. That's how I see it. You may see it differently. If you do, curious to hear from you. But if you want to fight back against this legislation, you can go to otplinks.com and fight back against that. piece of legislation, because I think that we need as a community to have our voices heard on this, especially those who have gotten healthier by way of compounded medications. So the rumor on the gray market, to get back and close the thought loop here, There's been no specific FDA cutoff announced, but what the rumors going around are that that the compounded versions of GLP ones, especially obesity medicine in the gray market, are all going to turn off like a sieve on January first. Now, I seem to feel like this is probably more of a marketing tactic by these companies to sell a whole bunch of peptides at the end of the year. I think that's probably creating some panic and probably panic buying on people's parts. And so these companies are benefiting greatly. Again, that's why there should be guardrails around this. There's no guardrails around this at all. I mean, at the end of the day, they can say whatever they want to say, so long as they cloak everything in research grade. And these rumors proliferate around and people spend thousands, tens of thousands of dollars. I've heard of people having twenty years worth of Retatrutide in their freezer. Why? For what purpose do you need that? So just a massive amount of money made in this gray market. And that's not to knock people who use it. I say this all the time, but I think it's worth qualifying the statement. It's not knocking people who use it. I get it. But at the same time, we're talking about an industry that is, there's no altruism here. They're in it for money just as much as Eli Lilly is, except they have actually done nothing in the way of advancing medicine. They've just taken intellectual property, copied it, and sold it to you with a label that says, don't put this in your body. So you know where I stand on the gray market. I've heard from many people who've been injured by gray market stuff. It's just what it is. It's a gray market. You're taking your health into your own hands. Please, whatever you're doing out there, as risky as it may be, please involve your doctor and let your doctor know what you're doing so you can be monitored for the things your doctor believes you should be monitored for if you're using this. But this all underscores, again, the need for accessibility to these medications, the need for us to be aware of the fact that a moat is already being built around the most advanced metabolic drug in the pipeline. And we just need to be aware so that when it comes time to fight, we're all ready and informed. And that's what this podcast is serving to do. Before we jump into the next topic, I do want to thank our sponsor, our headline sponsor of this podcast. is a company called Shed. Now, if you are looking for access to care for obesity, then look no further than our partners at Shed who believed in this podcast enough to help us do it full time. You can go to Trished.com and use code OTP25 to save twenty five percent at Trished.com, where you're going to get connected to a doctor who will when medically necessary prescribe medication to treat your obesity. You also get access to coaching. You'll get access to all sorts of medication, whether it's the branded or the compounded versions, depending on your specific situation. All of it is available at Trished.com. They use one of my favorite compound pharmacies in the game, Strive Pharmacy, which I've gotten the chance to dig into on my own. I really love what they do there. They're a It functionally operates a lot more like a 503B. Uh, and I think that they're doing great work over at a strive pharmacy. They partner with shed. So I just love this, this, and when we were looking for somebody to offer a compounded versions, I wanted to make sure that I trusted the pharmacy. People always ask me, Dave, who, who should I go to? I'm like the pharmacy matters more than anything because you want to trust the source of your medication. So try shed.com use code OTP25. Listen, you're going to want to learn about taking any new medication before you take it. Learn about the potential side effects. Learn about the trade offs. There's no free lunch, but all of the information that you're going to need, you can find it. Try shed.com and be familiarizing yourself with all of your options there. So thank you to Shed for being a wonderful partner here at On The Pen. Now let's talk about some data that dropped. We're talking about accessibility and all of the sort of advancements in the world mean very little if people can't access it. That's why I think this data that dropped this past week from our friends over at Rowe is incredible. Absolutely game changing data. So check out this data. Real world telehealth data looking at sixty eight weeks. This is looking at patients who were enrolled in their row body program and on a GLP one specifically some maglutide mean weight loss in this study looked at again patients in over sixty eight weeks. The mean weight loss was sixteen point six percent on average. Thirty three percent of patients lost more than twenty percent and the safety in this study and looking at this data match the clinical trials. So what we're seeing here is that care for obesity can be delivered through a telehealth platform at scale and match clinical trial results. So that scalability decides how many people get access. There are not enough doctors out there to serve the over hundred million people in the United States living with overweight or obesity. so when you hear these blowhard doctors online calling all telehealth platforms except their own a pill mill or as i like to say pin mill the data is actually showing something quite different in that this type of obesity care can be delivered at scale through telehealth platforms it can meet people where they're at and allow people to get care without the shame, without the stigma, without their doctor just pointing to the door and saying, if you want a GLP-I, get out of my office. I ain't going to get it here. How ridiculous. But these people can go to platforms like Rho or Shed or any number of telehealth platforms that are out there and not only get access to medicine, but get access to care. So of course, not all telehealth companies are created equal. Of course, not all compound pharmacies are created equal. You want to do your homework and all of that. But this is data that shows that This kind of care can be delivered at scale via a virtual platform and show similar results to a clinical trial. I think, and this is peer reviewed data, and I think that this is just absolutely great news because when we talk about the problem, we need scalable solutions. The old brick and mortar ain't going to work when you don't have enough doctors to serve enough patients. If we want to get life-changing treatments like ritatratide or terzapatide, semaglutide, whatever, into the hands of the people who need it the most, we need companies to innovate scalable tech platforms that can meet patients where they are, that can leverage current technologies to find people the care that they need. And in this case, it's access to a doctor. It's access to a platform. It's access to prescription medication when appropriately prescribed. And it can be done, and it is being done. So I think this is great news, and will play a huge part in the future. As we talk about Retatrutide, even though it's a year and a half away, maybe a little bit longer, it's already exposing – the issues around accessibility and pricing. Hopefully there will be compounded versions available if they're medically necessitated, if there are shortages. We hope that the battleground for that is not already set and won by Lilly before this drug even comes to market. But there are strategies being done to keep people boxed out But I can tell you that whatever happens with Retatrutide, the future of obesity medicine is in virtual care. And platforms are rising to the occasion. Retatrutide hasn't reached patients yet, but it's already forcing the system to show us, you know, are you ready? Are you ready to deliver bariatric surgery level results at scale to the people who need them? So I am so thankful that you joined me here on this podcast today. Again, we love to talk about we're at a Retatrutide. If you're interested, we've been going live every Monday, Wednesday and Friday at eleven a.m. Central Time here on our YouTube channel, on our tick tock, on our X platform. We're doing that because there's enough news to bring you just about every single day. And we've been doing it for the last couple of weeks. If you've enjoyed it, let me know in the comments of the video on YouTube. Send me an email at David on the pen dot com. Uh, so every single Monday, Wednesday, Friday, and then we do a weekly rundown of the obesity medicine news every Tuesday. That's what this is. The weekly dose podcast. You can catch this on all of the platforms that you listen to your podcasts on, and please make sure to leave us a five star rating and review before you log out of your podcast app. That helps so much. I don't think you guys understand how much that helps, uh, the work that we do here to just train the podcast algorithms that this one is worth listening to. I hope you enjoyed today's podcast. If you did, drop it a thumbs up, five-star review, subscribe on YouTube, do all the things. Thank you for being here, and thank you for being the best part of what we do. We will catch you on the next one. Thank you, my friends. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We talk about government bonds! Why the government issues these bonds. Why people buy these bonds (over stocks or putting money in a HYSA - High Yield Savings Account). Part of my series on money! To learn more about stocks, view my episode about: We Trust that In the Future We Trust.Sources:https://www.investopedia.com/articles/bonds/07/price_yield.asphttps://www.bankrate.com/investing/why-do-bond-prices-move-up-and-down/https://bondfish.com/readings/bond-vs-loan-understanding-the-main-differenceshttps://www.wallstreetmojo.com/bond-vs-loan/

Don't be shy, send me a message!Thomas Felix Creighton talks to David Zaritsky of 'The Bond Experience' about the Britishness of 1969's James Bond 007 adventure, 'On Her Majesty's Secret Service'.The movie has an Australian star, an American and a Canadian producer, and was certainly made for export... so why does this film feel so extremely 'British'?Listen to find out!You can find David at:Instagram: @thebondexperience Youtube: www.youtube.com/thebondexperiencePodcast: Search 'The Bond Experience' wherever you found this!Support the showhttps://www.albionneverdies.com/

Compliments of the season to you from the At The Flicks crew. If you are like us, then you will be watching at least one James Bond film this Christmas.  Goldfinger, You Only Live Twice and Live And Let Die are choices very popular with this team.  All classics. However, with James Bond somewhat cold at present and Amazon seemingly muddling through with the franchise, we have to ask the question – is the age of James Bond as we know it, over? And that is the subject of the At The Flicks Christmas lecture for this year.  It's a weighty subject, so we have to call on an expert to help address this question.  Bond fan Niall Browne from Movies In Focus joins Jeff and Graham to discuss how did we get here and Amazon's current handling of the James Bond legacy (clue, it's not off to a good start). Of course, a screenwriter and director have been allocated to a new Bond project.  We talk about both and assess if they are the right people for the job or is Amazon “front loading” with talent over ideas? Being life long James Bond aficionados, we also offer some advice on what could or should be next for the superspy – that is, we talk about what we would like to see. Also, we consider the right attributes for the next actor to play James Bond, and of course, like everyone else, we throw in some names. Some of which may be controversial. So, before you settle down with your Christmas Pud (British reference there) to watch Sean Connery, George Lazenby, Roger Moore, Timothy Dalton, Pierce Brosnan or Daniel Craig, why not give us a listen? And if you have ideas about Bond which are not being talked about, please let us know for a possible future follow up show as I am sure the James Bond story is going to change a lot during 2026. Until then, have a great Christmas. We will be back at year's end to share our top films of the year with you. Links Goldfinger Trailer

Chichester Chats Ep #51: Terror Inc. #8 "The Gift Of The Maggia"   Welcome back to the Chichester Chats! This time Phil and Lilith chat with D.G. Chichester about his story from Terror Inc. #8 (February 1993) featuring the undead mercenary in a Christmas story unlike any other. PLUS: Discussion on the next James Bond and what horror movie franchise was inspired by Terror Inc.?   Tune in today and don't forget to review the show on Apple Podcasts, Spotify, YouTube, and anywhere else you can!    Chichester Chats Links  → Bluesky https://bsky.app/profile/capesnetwork.bsky.social → Twitter https://www.twitter.com/ChichesterChats → Instagram https://www.instagram.com/capeslunatics/ → Facebook https://www.facebook.com/ChichesterChats → YouTube https://www.youtube.com/c/CapesandLunatics   ==================  

Am letzten Montag, den 8. Dezember, fand das 21. Symposium des Bundesamtes für Verfassungsschutz unter dem Motto „Zeitenwende – und jetzt?“ in Berlin statt. Wie der stern berichtet, wurde bei der dortigen Paneldiskussion besprochen, wie Deutschland angesichts der Bedrohung durch Russland resilienter werden und seine Nachrichtendienste für ihre Arbeit stärken könnte. Dabei habeWeiterlesen

This week, we take a look at Delphine's followup to Future Wars, Operation Stealth!

In this episode, Stuart and Jacob embark on a wild ride through the world of espionage as they look at the 1967 comedic spoof "Casino Royale" and the much more serious Daniel Craig iteration of 2006. They delve into the absurdity of the original film, which features a star-studded cast and multiple James Bonds, and discuss how its chaotic narrative pokes fun at the spy genre. Is it any good, spoofing a franchise that barely had existed by that point? Is the 2006 version the best of all the Bond films? Does Woody Allen suffer nearly enough?Also featured in this episode are diatribes about Edgar Wright's "The Running Man", an analysis of British comedy, praise for Mads Mikkelsen, and Stuart and Jacob even build their own spoofs. All this and more on They Remade It!Plot Synopsis Timestamps: 27:00 - 42:39----------Socials----------@theyremadeit.bsky.social on Blueskytheyremadeit@gmail.com

This week, we take a look at Delphine's followup to Future Wars, Operation Stealth!

Commander Mats, wir haben eine verschlüsselte Nachricht abgefangen. Sie lautet: BCDEACDFGDHEHI. Wir schicken Sie und Ihre Kollegin 00 Si eben lvia auf diese geheime Mission! Starten Sie bei Edgar, er wird Sie mit der nötigen Ausrüstung ausstatten. Ich vertraue auf Ihr Wissen und Ihre Aufmerksamkeit - wir werden das gegebenenfalls durch J prüfen lassen. Achja… Commander? Lassen Sie sich nicht wieder von Frau Dor ablenken. PS. F schickt Liebe̶-Grüße aus Dänemark. 100 Seiten James Bond - Karin Dor in YOLT - Hörbücher auf Audible - Ian Fleming - Eon Productions - Casino Royale 1954 - Sag niemals nie - John Barry Bond Theme - Goldfinger - Wallace Drehorte Folge - Gunbarrel Sequenz - Siegfried Schürenberg als M - George Lazenby Bond - Ms Moneypenny im Wandel - Q im Wandel - M im Wandel - John Cleese als Q - Blofeld im Wandel - Umberto Ecos Baukastensystem - Whodunnit - Bond taucht - Mondbuggy Verfolgungsjagd - Verfolgungsjagd mit Ente - Verfolgungsjagd mit Gondeln - Bond kritisiert die Beatles - Filmlocations London - MI6 Gebäude - James Bond fährt Ski - Bikini Szene - James Bond Tarantel - Der Zinker Schlange (ab 1:01:00) - Austin Powers - weitere Bondromane - Young Bond - Fröbe als Goldfinger - Lee als Scaramanga - Im Gehörgang Ihrer Majestät

DAMTT: Two-Legged Lamps, Jaws, and Choosing Wit After missing a week due to sickness, Stacy and Eric are together again! Stacy is knee-deep in prepping her house for sale, which is making her way less enthused to decorate her house, while per tradition, Eric's place is decorated, save for the tree which will go up eventually. Naturally this leads to a rabbit hole about real versus fake trees and holiday smells. Speaking of smells, Stacy had a sensory shopping experience that was doggone awful! Eric has some recent wins with both his deck and solar panels finally being done, just in time for the rain. As for Cultural Blindspots, Stacy has been WAY too busy watching bad holidating movies to check anything off the list whereas Eric checked off every James Bond movie featuring Roger Moore and Timothy Dalton. His take was the movies weren't terribly smart, but they were very funny, a theme that ties perfectly into this episode's topic of Smart vs. Funny. In the end Stacy and Eric agree that a smart person picks a funny one. DAMTT is on Facebook and Instagram as @dontaskme to talk or email asking@dontaskmetotalk.com Next Time: Is Water Wet?

Subscribe to Throwing Fits on Patreon. Year of the bozo. This week, Jimmy and Larry are putting their heads together on whether James Bond is a cop or a troop, footwear organization, a little personal order jacket mix up, electronica to listen to while on your bike, we are finally ready to dive headfirst into the big theoretical conversation we've been wanting to have on the current menswear affordability crisis and the claim that all clothes are the same now (read: boring) so that takes up a good portion of the show, big picture Fitties takeaways now that the nominees are locked like where have all the GOATs gone, sneakers are dead and gone, the collaboration market correction and politics as culture, it's almost Industry szn so we talk about our favorite show and our friends Mickey Down and Konrad Kay who were just profiled by The New Yorker, the incarceration corner debuts thanks to Jeremy O. Harris and Bonnie Blue getting locked up aboard and Jen Shah being freed and much more.

Ho ho… oh no, the Christmas countdown is on and we're nowhere near ready but the Chris Moyles Show podcast is here!This week we made history with a double billing on The Boffin Booth as Dom and James were quizzed on… melons. Yes, really serious stuff!Martin Compston was our first of many guests this week, recommending Red Eye series two as perfect New Years day telly. He shared his excitement of getting to live out his James Bond fantasy, playing an embassy security officer.Then, the big big boss man of F1's McLaren Zak Brown popped in to talk about the release of his book ‘Seven Tenths Of A Second', sharing some behind the scene stories from McLaren as he rides the high of Lando's recent win.Norman Cook, aka Fatboy Slim, joined us on Zoom with huge news that The Rolling Stones have finally cleared Satisfaction Skank for release, after nearly 30 years!! He also confessed to sometimes abandoning the decks mid-gig to dive into the crowd!And finally, Jimmy Carr came in to chat about his brand new film, drop some wisdom about live comedy and of course, unleash that famous laugh of his.And we're really spoiling you this week because there's MORE….!Stupid AmnestyPolly's punishmentThe book of foreign swearsEnjoy!The Chris Moyles Show on Radio X!Weekdays 6:30am - 10am

durée : 00:02:49 - La Chronique du Grand Continent - par : Gilles Gressani - Dans les temps étranges que nous vivons, il y a une règle : il faut toujours prendre au sérieux les gens qui ressemblent à des méchants de James Bond.

The Daily Quiz - Entertainment, Society and Culture Today's Questions: Question 1: In which year was Star Wars: Episode V - The Empire Strikes Back first released in the cinema? Question 2: Which actress played the role of Aurora Greenway in Terms of Endearment? Question 3: What flower has cultural significance for being associated with love? Question 4: What does the word 'diez' mean in Spanish? Question 5: What is the term for the ratio of a company's total revenue to its total expenses? Question 6: Who played the role of James Bond in Casino Royale? Question 7: Which of the following describes Isaac Newton? Question 8: In which year was Apocalypse Now first released in the cinema? Question 9: In which year was The Dark Knight first released in the cinema? This podcast is produced by Klassic Studios Learn more about your ad choices. Visit megaphone.fm/adchoices

Although James Bond is one of the most beloved film franchises in cinema history, quite a lot of the films remain rather unloved. So we're going to give those ones a closer look, starting this week with the two films that, according to Letterboxd, are the least watched entries in the official EON canon. Nick Langdon pops in and checks out For Your Eyes Only (1981), directed by John Glen, and also Glen's fourth directorial effort in the franchise, The Living Daylights (1987). We don't think it's really possible to spoil any of the James Bond films - surely, they've all seeped fully into the pop culture consciousness by now - so we won't be calling out Spoiler Territory for either film this week. Want to get in touch? You can reach us on caliber9fromouterspace@gmail.com Theme music: "The Cold Light of Day" by HKM. Check out HKM on #SoundCloud or Bandcamp "For Your Eyes Only" by Blondie

Prep school Nazis have destroyed America

SPECIAL! -- Merry Christmas and Happy Holidays! We're back with another 12 James Bond Holiday Gift Ideas 2025! Check out the video on YouTube for links to each item!  You can find Being James Bond at… • Being James Bond | http://www.beingjamesbond.com • Facebook | https://www.facebook.com/Being-James-Bond-17631406474/ • Twitter | http://twitter.com/headofsection • Instagram | https://www.instagram.com/beingjamesbond/ • iTunes | https://itunes.apple.com/us/podcast/being-james-bond/id205222801?mt=2 • Check out REVIEWS WITHOUT REMORSE | https://www.youtube.com/@reviewswithoutremorse168

Ajay Chowdhury reveals how the new James Bond Locations Atlas Darker Than The Sun maps 007's world like never before, blending real geography with film secrets and behind-the-scenes stories. Shane Whaley is joined by returning guest and leading James Bond authority Ajay Chowdhury. Co-author of the newly released James Bond Locations Guide Darker Than the Sun. This isn't your typical location guide, though. Darker Than the Sun is an immersive, richly visual atlas that blends real geography, fictional locales, and behind-the-scenes insights into how Bond movies have mapped and redefined the spy film landscape. Buy The Book - https://geni.us/OIdoqSA Grab Tim Shipman's Top 125 Spy Authors Ranked - https://www.spybrary.com/top125 Ajay Chowdhury reveals how Darker Than The Sun distinguishes itself from other James Bond location books, and why it's both a travelogue and a love letter to the artistry of filmmaking. With fascinating anecdotes, deep research, and stunning photography, the book peels back the layers of artifice behind Bond's most iconic locations — from Crab Key and Montenegro to Swindon doubling as Azerbaijan! Whether you're a Bond obsessive or a travel lover, this episode reveals why Darker Than the Sun belongs on your coffee table.

In this episode, I spoke with author Thom Shubilla about his latest book "King Kong vs Godzilla -"The Most Colossal Conflict the Screen Has Ever Known". Popular culture in 1962 experienced many notable firsts. That year, The Beatles released their debut single “Love Me Do” in England, The Beach Boys first LP, Surfin' Safari, was stocked on record store shelves, The Rolling Stones played their first shows, Dr. No marked the opening James Bond adventure to hit theaters, Marvel Comics' “The Incredible Hulk” was splashed on the pages of comic books—and two of the greatest movie monsters, King Kong and Godzilla, clashed on the big screen.

Vaseem Khan is the mastermind behind the newest installation in the James Bond universe. His new novel ‘Quantum of Menace' follows gadget mastermind Q, after he is ousted from MI6, Q is thrown into a dangerous conspiracy as he investigates the death of his scientist friend. Award winning crime writer Vaseem Khan joined Pat to chat all about his brand-new spinoff series.

This week, Taylor, Sandy, Doug Jordan and Taddea Richard discuss a huge break in the wrongful Matthew Perry suicide case, a wedding accident, the next James Bond, Ethan Hawke's Robin Williams revelation, trouble with ICE and much, much more! Thirty Days of Christmas continues with an all new segment entitled Our Week's: 30 Days of Christmas Segment Ideas! Carol Of The Bells by Audionautix is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Artist: http://audionautix.com/

The journey to becoming a published author is rarely a straight line, but few paths have been as globally adventurous, or involved a greater number of pachyderms and famous spies, as that of Vaseem Khan.From his decade living in India to his new role continuing the legacy of James Bond's very own gadget master, Q, here are the key takeaways and inspiration points from a writer who proves that persistence truly is the only non-negotiable trait in this business.100 Rejections and the Power of Persistence.Vaseem's story is a powerful reminder that rejection is not destiny, it's just part of the process.After being encouraged by an English teacher in school, he wrote his first novel, a comic fantasy, at the age of 17. The response? A swift, harsh rejection. This was followed by a staggering two decades of writing and seven more rejected novels across various genres.* A Brutal Education: Over that period, Vaseem collected over a hundred rejection letters, describing the feeling as “like being kicked in the bollocks repeatedly every few years.”* The Commitment to the Dream: What kept him going was the fundamental love for books and the idea of being a writer. He believes those who last the course never give up on that core dream.* The Breakthrough Moment: His career finally launched at age 40 when he tapped into his personal experience: his 10 years living in India. He wrote The Unexpected Inheritance of Inspector Chopra - a crime novel set in modern Mumbai featuring a serious policeman who inherits a baby elephant. His editor loved it precisely because it was “completely different to anything we'd seen in the crime fiction market.”Vaseem's Advice on Finding Your Voice: You have to write what you know, or at least, what you are uniquely positioned to write. The trick is to do something “completely different, but the same, take an established genre, stick to its core beats, but tweak the formula just enough to offer a unique perspective.”Commissioned by Ian Fleming: The Q Mystery Series.Perhaps the most exciting new development in Vaseem's career is his commission by the Ian Fleming Estate to continue the story of James Bond's gadget master, Q.The request was clear: they did not want another straight spy novel.* The Perfect Pitch: The Estate asked for “something halfway between Mick Herren's Slow Horses and Richard Osman's Thursday Murder Club.“* The Premise: In the first book, Quantum of Menace, Q is booted out of MI6 at age 50. He returns to his small hometown, having left a “messy past behind,” to reinvestigate the mysterious death of a childhood friend. The hope is that he will evolve into an amateur detective, solving mysteries in this small-town setting.* The 007 Cameo: For Bond fans, Vaseem confirmed that he's included plenty of Easter eggs, and Commander James Bond “does make a meaningful appearance in the second half of the book.”The Single Most Important Piece of Writing AdviceWhen asked for the one crucial tip he gives in his workshops, Vaseem didn't hesitate:“The number one reason that books are rejected by agents is because the quality of the book does not meet their minimum standard for them to be able to have confidence sending it out to a publisher.”His concrete advice is to focus on craft before submission:* Understand Your Genre: Know the standards for prose, plotting, and characterization required for your specific genre (e.g., crime fiction needs a strong hook and right ‘beats' over literary prose).* Get Quality Feedback: You must get feedback. Don't rely solely on friends; consider paying an experienced, trusted editor who has a proven history in the industry.* Don't Ruin the Hook: You normally only get one good chance with a brilliant idea. Bad execution will ruin your chance with an agent, forcing you to write something else. Make the best possible fist of your manuscript before you send it in.Vaseem's interview was a masterclass in commitment, creativity, and the power of finding that one unique idea that can change everything. You can find his books, including his new Q novel, on his website and at all major bookstores.Catch the full interview with Vaseem Khan on our YouTube channel: This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit thewccs.substack.com/subscribeBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-writing-community-chat-show--5445493/support.

The 1960s were a defining era for James Bond, and much of that success came from its unforgettable villains. In this episode, we dive deep into How James Bond Villains of the 1960s shaped the 007 franchise, exploring the masterminds who turned spy thrillers into global phenomena. From the calculating genius of Ernst Stavro Blofeld to the gold-obsessed Auric Goldfinger, these characters didn't just challenge Bond—they set the standard for cinematic villains for decades to come. We'll examine how these antagonists influenced the tone, style, and storytelling of the early Bond films. Why did Blofeld become the ultimate symbol of evil? How did Goldfinger's obsession with wealth redefine villainy? And what about Rosa Klebb? How did she add psychological depth to espionage drama? Each villain brought unique traits that shaped Bond's evolution as a character and cemented the franchise's identity. This episode also looks at the cultural impact of these villains. Their extravagant lairs, iconic henchmen, and world-domination plots became templates for countless spy movies and even parodies. We'll uncover behind-the-scenes details, including casting choices, design decisions, and how Ian Fleming's novels influenced their on-screen portrayals. Whether you're a lifelong Bond fan or new to the series, this discussion offers fresh insights into why the 1960s villains remain legendary. They weren't just bad guys—they were trendsetters who defined an era of cinematic sophistication and suspense. Tune in to learn how these iconic adversaries shaped the legacy of 007 and why their influence still resonates in modern spy films. Subscribe now and join us as we revisit the decade that made James Bond—and his villains—immortal. Tell us what you think about our decoding of how James Bond villains of the 1960s shaped the 007 franchise Finally, do you agree with our assessment here?  Drop us a note and let us know. Let us know your thoughts, ideas for future episodes, and what you think of this episode. Just drop us a note at info@spymovienavigator.com.  The more we hear from you, the better the show will surely be!  We'll give you a shout-out in a future episode!   You can check out all our CRACKING THE CODE OF SPY MOVIES podcast episodes on your favorite podcast app or our website. In addition, you can check out our YouTube channel as well.   Episode Webpage:  https://bit.ly/bond-villains-of-the-1960s

Terence Young's 1963 sophomore installment in the James Bond franchise, FROM RUSSIA WITH LOVE, is our feature presentation this week! We discuss key lore beginnings with S.P.E.C.T.R.E, the director's dislike of Daniela Bianchi's legs, Sean Connery, the helicopter crash that nearly brought David Lean onto the film, and more! We also pick our Top 7 Russian-Related Movies in this week's Silver Screen 7!  Join our Patreon ($2.99/month) here linktr.ee/brokenvcr to watch the episodes LIVE in video form day/weeks early. Find us on Instagram @thebrokenvcr and follow us on LetterBoxd! Become a regular here at THE BROKEN VCR!

The Prisoner, Patrick McGoohan, Danger Man, David Tomblin, Orson Wells, Wells' influence on McGoohan, Theater of the Absurd, 60s spy series, The Prisoner as a critique of the propaganda in spy dramas, James Bond, McGoohan's refusal to play Bond, McGoohan's post-Prisoner work, Columbo, McGoohan's political beliefs, the influence of McGoohan's Catholicism, George Markstein, Special Operations Executive (SOE), Markstein's journalism career, Markstein's rumored intelligence ties, Inverlair as a model for the Village, Markstein vs McGoohan for credit in creating The Prisoner, mind control/brainwashing, mind control often framed as strictly Soviet method in era Prisoner came out in, Lincoln Lawrence's Were We Controlled?, JFK assassination, public mind control debate after JFK assassination, did Lawrence influence The Prisoner?, MK-ULTRA/ARTICHOKE, AI, Electioneering, ESP, how casually The Prisoner shows ESP, where did The Prisoner's in-depth knowledge of mind control techniques come from?Music by: Keith Allen Dennishttps://keithallendennis.bandcamp.com/ Hosted on Acast. See acast.com/privacy for more information.

DeHuff kicks things off with a story from his annual physical, recalling an awkward moment with a female doctor that still lingers in his mind.  From there, things get wild around the globe—starting with a New Zealand man who swallowed a Fabergé pendant inspired by the James Bond film Octopussy, forcing police to sift through his feces to get it back. Detroit enters the chat with their newly erected RoboCop statue, prompting a hilarious discussion about which other cities should honor their iconic movie characters.  Meanwhile in Virginia, a raccoon breaks into a liquor store and gets absolutely plastered, proving once again that wildlife knows no boundaries. Sports heat up as the Denver Broncos sit atop the AFC while the Kansas City Chiefs watch their nine-year AFC West streak slip away. Shedeur Sanders boosts his trade value after a standout game against the Titans, sparking debate about his future. Plus, a look at companies that wildly overthink their social media posts, and a breakdown of how college football bowls and playoffs could be fixed once and for all. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Welcome to a special episode of OHMSPod! Join Jarrod Alberich for a special interview! This episode features an interview with Flint Dille - writer/producer who worked on "Tomorrow Never Dies" on the PlayStation!  Flint give us his insights on the game's production, some additional Bond talk, and even some talk around the production of the Mission: Impossible video game. Be a part of the White Rocket Entertainment family by becoming a patron of the shows-we thank you by name on every episode: https://www.patreon.com/vanallenplexico Brought to you by White Rocket Entertainment and by Audible.com. Find links to everything we do at www.plexico.net

Vuelve a La Órbita de Endor el espía de ficción por antonomasia: JAMES BOND, el agente 007, en esta ocasión con la encarnación de Pierce Brosnan en la que fue su primera película de la saga: GOLDENEYE. Junto a Elia Míriel, Jaime Angulo, Antonio Monfort y Antonio Runa repasaremos toda la historia de la producción, con el cambio de era, el complejísimo rodaje y se analizará la trama de la película de principio a fin. Es un podcast con licencia para matar y es todo para ti. Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

Welcome back to another episode of Pluribus by Story Archives. Hosts Mario Buso and Zachary Newton dive into episodes five and six, titled 'Got Milk' and 'HDP' (Human Derived Protein). Both hosts share their personal room renovation projects and discuss the latest dramatic developments in Pluribus. Mario highlights his new relaxed podcast set-up and renovations, while Zach recounts his ceiling repainting experience. They review major plot points such as Carol's frightening discoveries, the hive mind's moral complexity, and the mysterious Manus from Paraguay. They also speculate on future storylines, including the potential for an alien invasion and developments in the show's overarching mystery. Additionally, there's a fun comparison to James Bond, exploring potential actors suitable for the role. The episode ends with their picks for favorite scenes, reinforcing their excitement for the next Pluribus episodes.00:00 Welcome and New Beginnings00:16 Home Renovations and Setups03:45 Thanksgiving Recap and TV Shows04:07 Pluribus Episode Discussions05:40 The Hive Mind and Moral Dilemmas07:16 Character Dynamics and Predictions18:01 Alien Theories and Sci-Fi Tropes20:53 Diante's Lifestyle and Future Speculations33:05 Alien Signal and Writer's Room Speculations33:52 Landing the Plane: TV Show Endings35:32 Vince Gilligan's Mastery and Comedic Timing36:32 Hive Mind and Character Dynamics40:26 Comparing Shows and Episode Highlights47:40 James Bond Casting Speculations58:54 Concluding Thoughts and FarewellKeep up with all things Story Archives Official Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠soapbox.house⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: ⁠⁠⁠contact@soapbox.house⁠⁠⁠Support this show: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠PayPal⁠⁠⁠Follow the hosts on Instagram:⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠@mariobusto @zacharyrnewtonMario's Production Company: 1992films.comZachary's Design Company: zacharyrnewton.com

Is this prank taking things too far? Also, what kind of deals can you get for Candle Day? We talk about our Spotify Wrapped results, Callum Turner emerging as the favorite to play the next James Bond, and lots more!

In the 1960s, America was confident and united. The Beach Boys were on the radio, families were intact, heroes were celebrated, and nobody was confused about what a man or a woman was. Today, our culture is bitter, divided, and confused—and the Left calls that “progress.”In this episode of Life Lessons with Dr. Bob, Dr. Bob sits down with writer, filmmaker, and commentator Bill Whittle to answer one big question: What happened to the country we grew up loving—and can we get it back?Bill explains how cultural Marxism and the Frankfurt School quietly burrowed into universities, media, and entertainment, replacing E pluribus unum with endless tribalism and victimhood. They connect this long march through the institutions to today's headlines: the Left's reaction to October 7th, the way Hamas uses its own civilians as propaganda, and why so many in the West automatically side with “the weaker party” instead of asking who is actually right.Together, they dig into:

Full shownotes are available on ⁠the website⁠: In this episode we interview Scott Hardy from SpyHards. You can buy tickets to the event that Spyhards is putting on at Riverside Studios in Hammersmith, here. There is a breakdown of my dinner with Steven Berkoff (General Orlov in Octopussy)We break down minute 19&20 of OHMSS. For listener mail : therewillbebond@gmail.comThis month we are partnered with ⁠Wilde & Harte⁠ Razors and ⁠Prop Store⁠.Use TAILORS20 for a discount at W&H. Join us on Patreon for as little as a pound week. https://www.patreon.com/c/ThereWillBeMoreBondEpisode #109S2.008

A jock ghost trapped with nerds/Are some diseases made up?   Patreon (Get ad-free episodes, Patreon Discord Access, and more!) https://www.patreon.com/user?u=18482113 PayPal Donation Link https://tinyurl.com/mrxe36ph MERCH STORE!!! https://tinyurl.com/y8zam4o2 Amazon Wish List https://www.amazon.com/hz/wishlist/ls/28CIOGSFRUXAD?ref_=wl_share Dead Rabbit Radio Recommends Master List https://letterboxd.com/dead_rabbit/list/dead-rabbit-radio-recommends/ Dead Rabbit Radio Archive Episodes https://deadrabbitradio.blogspot.com/2025/07/ episode-archive.html https://archive.ph/UELip   Links: EP 1272 - Revenge Of The 5 Year Old Witch! (Witch Cemetery Ghost Story Based On Real Person episode) https://deadrabbitradio.libsyn.com/ep-1272-revenge-of-the-5-year-old-witch EP 926 - Was Jon Benet Ramsey An A.I. Created By Demons? (A.I. episode) https://deadrabbitradio.libsyn.com/ep-926-was-jon-benet-ramsey-an-ai-created-by-demons The Shadowlands Kentucky (Fort Thomas, Kentucky Highlands High School David Cecil Football Player Trapped Music Room Peering Through Windows Ghost story) http://www.theshadowlands.net/places/kentucky.htm Archive https://archive.ph/U1ZV7 Who Was Highlands' David Cecil? https://linknky.com/uncategorized/2016/11/22/who-was-highlands-david-cecil/ David Cecil Stadium https://stadiumconnection.com/stadium.php?id=1410 Street Class: Most Haunted Places in Fort Thomas https://linknky.com/uncategorized/2014/10/14/street-class-most-haunted-places-in/ Is your high school haunted? Here are 11 spooky ghost stories about Kentucky schools https://www.courier-journal.com/story/life/holiday/2023/10/20/is-your-high-school-haunted-11-spooky-stories-about-kentucky-schools/71036214007/ What does Morgellons disease look like, and what are the treatments? https://www.medicalnewstoday.com/articles/morgellons-disease Classification and Staging of Morgellons Disease: Lessons from Syphilis https://pmc.ncbi.nlm.nih.gov/articles/PMC7012249/ History of Morgellons disease: from delusion to definition https://pmc.ncbi.nlm.nih.gov/articles/PMC5811176/ Under My Skin https://archive.is/0U7j7 Morgellons https://en.wikipedia.org/wiki/Morgellons Delusional parasitosis https://www.mayoclinic.org/diseases-conditions/mental-illness/in-depth/delusional-parasitosis/art-20044996 What Is Morgellons? https://resources.healthgrades.com/right-care/skin-hair-and-nails/morgellons Delusional infestation versus Morgellons disease https://www.sciencedirect.com/science/article/abs/pii/S0738081X18301780 The challenge of Morgellons disease: A patient with clinicopathologic correlation https://www.sciencedirect.com/science/article/abs/pii/S0738081X22000906 Federal study of Morgellons yields no answers https://www.cbsnews.com/news/federal-study-of-morgellons-yields-no-answers/ Federal study of Morgellons yields no answers https://www.cbsnews.com/news/federal-study-of-morgellons-yields-no-answers/ Morgellons Disease is Not a Delusion, Says New Study https://www.lymedisease.org/morgellons-disease-not-delusion-says-new-study/ Fibromyalgia https://www.mayoclinic.org/diseases-conditions/fibromyalgia/symptoms-causes/syc-20354780 Helen Keller flying a plane? https://www.reddit.com/r/Retconned/comments/1p79yv0/helen_keller_flying_a_plane/ How Did Helen Keller Fly a Plane? https://www.britannica.com/story/how-did-helen-keller-fly-a-plane Chucky Punch https://archive.ph/iX3t4 The girl with braces in James Bond Moonraker! (Jaws' girlfriend) https://www.reddit.com/r/MandelaEffect/comments/mu07n0/the_girl_with_braces_in_james_bond_moonraker_jaws/ Mandela Effect? ...or not? https://www.reddit.com/r/JamesBond/comments/1e5iiwc/mandela_effect_or_not/   ---------------------------------------------- Logo Art By Ash Black Opening Song: "Atlantis Attacks" Closing Song: "Bella Royale" Music By Simple Rabbitron 3000 created by Eerbud Thanks to Chris K, Founder Of The Golden Rabbit Brigade Dead Rabbit Archivist Some Weirdo On Twitter AKA Jack YouTube Champ: Stewart Meatball Reddit Champ: TheLast747 The Haunted Mic Arm provided by Chyme Chili Forever Fluffle: Cantillions, Samson, Gregory Gilbertson, Jenny The Cat Discord Mods: Mason, Rudie Jazz   http://www.DeadRabbit.com Email: DeadRabbitRadio@gmail.com Twitter: https://twitter.com/DeadRabbitRadio Facebook: www.Facebook.com/DeadRabbitRadio TikTok: https://www.tiktok.com/@deadrabbitradio Dead Rabbit Radio Subreddit: https://www.reddit.com/r/DeadRabbitRadio/ Paranormal News Subreddit: https://www.reddit.com/r/ParanormalNews/ Mailing Address Jason Carpenter PO Box 1363 Hood River, OR 97031 Paranormal, Conspiracy, and True Crime news as it happens! Jason Carpenter breaks the stories they'll be talking about tomorrow, assuming the world doesn't end today. All Contents Of This Podcast Copyright Jason Carpenter 2018 - 2025  

Dave and Chuck the Freak talk about things to look forward to in December, Al Roker gave kid Golden Ticket and she wasn’t pleased, old story of Cabbage Patch Kids on Black Friday, complicated pizza order, things that are normal to have one of but not 2, woman tried to stab BF at Thanksgiving, shooting at mall on Black Friday, 2 ladies driving crashed into tree and went into water, FedEx driver crashed into creek, life saved by pet rabbit, Cort tried Dave’s sweet cream, man stabbed in parking lot after UofM-OSU game, kid who is world champion bull rider, 50 Cent’s Diddy doc, Amy Schumer pictured without wedding ring, new name in running for James Bond, Clooney lost out on role to Brad Pitt, Johnny Cash estate suing Coke, Dolly asked about wearing wigs by bald man, Chinese man had lighter in stomach for 30 years, people arrested for Florida Keys threesome in public, road rage incident, woman gained 2 lost sisters on 23 & Me, cat loose on plane, someone walked in on guy in plane bathroom, OnlyFans star busted peeing over stuff in store, teacher struck by lightning, Hertz AI scanners, unintended date you share when you post pictures, Oxford Dictionary word of the year: Rage Baiting, 90-year-old man still skateboarding, missing art found in home put up for sale, and more!

Today on The Lou Perez Podcast I am joined by Ibrahim Pataudi, the co-founder and chief revenue officer of Armanet. We talk about gun censorship, James Bond censorship, the prevalence of doom, hunting in Pakistan, and drones for personal defense. Check out my book, That Joke Isn't Funny Anymore: On the Death and Rebirth of Comedy https://amzn.to/3VhFa1r     Watch my sketch comedy streaming on Red Coral Universe: https://redcoraluniverse.com/en/series/the-lou-perez-comedy-68501a2fd369683d0f2a2a88?loopData=true&ccId=675bc891f78f658f73eaa46d  Rock XX-XY Athletics. You can get 20% off your purchase with promo code LOU20. https://www.xx-xyathletics.com/?sca_ref=7113152.ifIMaKpCG3ZfUHH4  Support me at www.substack.com/@louperez     Join my newsletter www.TheLouPerez.com   Apple: https://podcasts.apple.com/.../the-lou-perez.../id1535032081   Spotify: https://open.spotify.com/show/2KAtC7eFS3NHWMZp2UgMVU   Amazon: https://music.amazon.com/.../2b7d4d.../the-lou-perez-podcast   YouTube: https://www.youtube.com/playlist?list=PLb5trMQQvT077-L1roE0iZyAgT4dD4EtJ   Lou Perez is a comedian, producer, and the author of THAT JOKE ISN'T FUNNY ANYMORE: ON THE DEATH AND REBIRTH OF COMEDY. You may have seen him on Gutfeld! , FOX News Primetime, One Nation with Brian Kilmeade, and Open to Debate (with Michael Ian Black). Lou was the Head Writer and Producer of the Webby Award-winning comedy channel We the Internet TV. During his tenure at WTI, Lou made the kind of comedy that gets you put on lists and your words in the Wall Street Journal: “How I Became a ‘Far-Right Radical.'” As a stand-up comedian, Lou has opened for Rob Schneider, Rich Vos, Jimmy Dore, Dave Smith, and toured the US and Canada with Scott Thompson. Lou has also produced live shows with Colin Quinn, the Icarus Festival, and the Rutherford Comedy Festival. For years, Lou performed at the Upright Citizens Brigade Theater (both in NYC and L.A.) in sketch shows with the Hammerkatz and his comedy duo, Greg and Lou. Greg and Lou is best known for its sketch "Wolverine's Claws Suck," which has over 20 million views on YouTube alone. In addition to producing sketch comedy like Comedy Is Murder, performing stand-up across the country, and writing for The Blaze's Align, Lou is on the advisory board of Heresy Press, a FAIR-in-the-arts fellow, and host of the live debate series The Wrong Take and The Lou Perez Podcast (which is part of the Lions of Liberty Podcast Network). Learn more about your ad choices. Visit megaphone.fm/adchoices

Don't have time to listen to the entire Dave & Chuck the Freak podcast? Check out some of the tastiest bits of the day, including Al Roker giving a girl a Golden Ticket, the next James Bond, teacher struck by lightning, and more!

In this episode of Cracking the Code of Spy Movies, Dan and Tom uncover the hidden history of pre-title sequences long before James Bond ever ordered a martini. We look at pre-title sequences – before James Bond and Beyond. Although the 007 franchise made the pre-title or "cold open" world-famous, it certainly didn't invent the idea. Today, we take you on a deep, cinematic journey exploring when pre-title sequences really began, how filmmakers used them, and why they evolved into one of the most iconic elements of modern filmmaking. What we examine: We break down pre-title sequences starting in the 1930s through more modern movies, including film noir innovations, experimental openings from classic Hollywood, and surprising influences that shaped the James Bond formula. You'll hear examples from Double Indemnity, The Killers, D.O.A., The Great Train Robbery, Citizen Kane, Casablanca, North by Northwest, Psycho, and more. We even examine the fascinating proto-Bond styles found in Viennese Nights (1930), The Public Enemy, King Kong, and other early films that used storytelling before the title card. Then we explore how EON Productions transformed the cold open into a cinematic event. Starting with From Russia with Love (1963), the Bond franchise turned the pre-title sequence into a mini-story before the story, complete with action, intrigue, a fake-out death, and a seamless transition into the iconic Bond title design. Movies like Goldfinger perfected the formula, cementing the expectation that every Bond film begins with a thrilling pre-title mission. We also identify earlier cinematic influences on the Bond gun-barrel sequence. This includes the 1934 film Crime Without Passion and the legendary ending of The Great Train Robbery. Finally, we look at how James Bond's success inspired other genres such as action, horror, and thrillers. We even look at television shows like Mission: Impossible and The X-Files. This is to demonstrate how these shows and movies embrace the cold open as a storytelling weapon. If you love movie history, spy films, James Bond, or filmmaking craft, this episode is packed with insights, references, and fun analysis. Tell us what you think about our decoding of pre-title sequences – before James Bond and beyond? Did you already know this history?  Did we miss anything? Let us know your thoughts, ideas for future episodes, and what you think of this episode. Just drop us a note at info@spymovienavigator.com.  The more we hear from you, the better the show will surely be!  We'll give you a shout-out in a future episode!   You can check out all our CRACKING THE CODE OF SPY MOVIES podcast episodes on your favorite podcast app or our website. In addition, you can check out our YouTube channel as well.   Episode Webpage: https://bit.ly/49PVHSE  

"I'm talking about his..." Dan has his own version of a Tony's Top 5 for the NFL Weekend before we get to Amin's Weekend Observations. Or, we at least TRY to get to Amin's Weekend Observations. His internet is awful, just like how Dan would look in Daniel Craig's speedo from James Bond. Learn more about your ad choices. Visit podcastchoices.com/adchoices

The team is back after the turkey day holiday and, boy, do they have stories to tell! Like, Bradley's wet turkey and Dawn's big surprise! The blinds are joined by special guest player, Britney! The other one. There's plenty of hot gossip about James Bond and Mariah Carey. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

They're two of the greats of their generation so it's no surprise that when they come together something special emerges, namely Chloe Zhao's HAMNET. Jessie Buckley and Paul Mescal return to the podcast to talk about their very emotional film, how they literally danced off set to Rihanna, and their plans to reunite....in a James Bond film? UPCOMING EVENTS Walker Scobell 12/19 in NYC -- ⁠⁠⁠Tickets here⁠⁠⁠ Check out the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Happy Sad Confused patreon here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠! We've got discount codes to live events, merch, early access, exclusive episodes, video versions of the podcast, and more! Learn more about your ad choices. Visit megaphone.fm/adchoices

Jay Dyer joins Gerald to discuss the journey to orthodoxy, Hollywood cult behavior and why James Bond is fighting the devil. Go to http://xlear.com/ use code LWC20 for a 20% discount.